Thyroid cancer is the most common malignancy in the endocrine organs. Papillary thyroid carcinoma (PTC) is the representative pathological type, constituting about 90% of thyroid cancers. Male gender, age, tumor size, extrathyroid extension, node metastasis, and distant metastases are well established prognostic factors in papillary carcinoma that can be evaluated preoperatively [1] [2] [3] . PTC shows a unique biological behavior related to age at surgery. Elderly patients with PTC generally show a poorer disease-specific survival than middle-aged or young patients [4] [5] [6] [7] . Young patients with PTC show high recurrence rates yet excellent survival [8, 9] . These confusing age-related phenomena are not explained well.
Postoperative PTC patients with detectable serum thyroglobulin (Tg) after total thyroidectomy are assumed to have residual tumors or hidden metastases [10, 11] ; this situation implies "biochemically persistent disease (BPD)." In 2011, we calculated the Tg-doubling time (DT) in BPD patients using serum Tg values measured under thyrotropin (TSH)-suppressed conditions, and we reported that the Tg-DT was a very potent prognostic indicator in patients with PTC and undetectable Tg antibody (TgAb) [12] . When we examined Tg-DT together with the classical prognostic factors in multivariate analyses of recurrence and disease-specific survival, only Tg-DT remained significant [12] . In the present study, in order to identify factors that are related to BPD and Tg-DT, we performed new analyses on the same data gathered for our previous study. With these analyses, we found that patient age at surgery was related to BPD and Tg-DT, findings that might provide new insight into the age-related phenomena mentioned above. gery was related to BPD and Tg-DT. In the present study, therefore, patients were divided into three age groups according to their age at the time of their surgery. As cut off points of age, 60 years was selected as described below, and 40 years was selected tentatively. There were 84 young patients (<40 years), 228 middle-aged patients, and 114 elderly patients (≥60 years). Each age group had clinicopathologic features that were significantly different from those of the others (Table 1) . Male patients were more common in the elderly group than in the other groups. The middleaged group had smaller tumors than the other groups. Significant extrathyroid extension (Ex2; equivalent to pT4a in TNM classification) increased with age, whereas clinical lymph node metastasis in the lateral neck (cN1b) decreased with age.
Factors related to biochemically persistent disease
BPD (biochemically persistent disease) indicates the presence of residual tumor(s) or hidden metastases. Here, the percentages of patients with BPD were significantly higher in both the young patients and the elderly patients compared to the middle-aged patients, at 41%, 41%, and 27% respectively: p = 0.0261 and p = 0.0094, respectively (Fig. 1, Table 2 ). However, the multivariate analysis (excluding the 14 patients with M1 disease) revealed that cN1b, tumor size ≥4 cm, and Ex2 were significant prognostic factors for BPD with the hazard ratios of 4.54, 2.20, and 1.75, respectively and that age ≥60 years was marginally insignificant (Table 3) . Age <40 years was not a significant factor for BPD. These results indicate that the risk of having residual tumors or hidden metastases postoperatively correlates strongly with the extent of disease status.
Factors related to thyroglobulin-doubling time
Tg-DT was computed in the 142 patients with BPD. Since all patients who died of the disease in the present cohort had Tg-DT <2 years, and since Tg-DT of 6 years divided patients with Tg-DT longer than 2 years into two patient groups of similar numbers, in the present study, the patients were grouped according to Tg-DT using these cut-off points. There were 33 (23%) patients with Tg-DT <2 years, 20 (14%) patients with Tg-DT greater than 2 years to less than 6 years, and 17 (12%) patients with Tg-DT ≥6 years. Tg-DT was of negative value in 72 (51%) patients since their Tg values decreased over time. The proportion of patients with postoperative Tg status and the Tg-DT categories
Patients and Methods
We performed new analyses on the data of 426 patients with papillary thyroid carcinoma who underwent total thyroidectomy at Kuma Hospital, Japan between January 1998 and December 2004. During this period, rather advanced cases or cases with bilateral lesions underwent total thyroidectomy, and central and ipsilateral neck dissections were routinely performed as therapeutic or prophylactic procedures by several experienced surgeons. These cases were described in our previous paper [12] . Very briefly, all patients underwent total thyroidectomy for PTC and had a negative TgAb test result. There were 349 females and 77 males aged from 14 to 81 years, with a mean age of 51.5 years. Distant metastases were detected in 14 patients at the time of surgery who were classified as M1 in the UICC TNM classification system [13] . The patients had four or more serum Tg measurements with serum thyrotropin (TSH) suppressed to <0.1 mIU/L. The Tg-DT was calculated in 142 (33%) patients who had four or more detectable Tg measurements. These patients were regarded as having BPD. There were 196 (46%) patients who had four or more undetectable Tg measurements only. They were regarded as being in "biochemical remission." In the remaining 88 (21%) patients who had one to three detectable Tg values and undetectable Tg measurements, Tg-DT was not calculated. These patients were regarded as having "an equivocal status." The patients were followed for a median of 86.7 months. During the study period, six patients died of the disease, 58 developed loco-regional recurrences, and 25 developed distant metastases.
The significance of differences in the variables among groups was calculated using the chi-square test or Fisher's exact test. The Cox proportional hazard regression model with stepwise variable selection techniques was adopted for the multivariate analysis. All statistical tests were two-sided, with the level of significance established at p<0.05. Statistical analyses were performed using StatFlex v6.0 (Artech Co., Osaka, Japan).
The Ethical Committee of Kuma Hospital approved this study.
results

Clinicopathologic features according to age groups
In our preliminary analysis, we found that age at sur- cut-off point for age, we tried several cut-off points for age: 50, 55, 60, and 65 years. The analyses gave the following p-values and hazard ratios for these ages: 0.0026 and 4.80 for 50 yrs, 0.0003 and 5.68 for 55 yrs, 0.0000 and 6.72 for 60 yrs, and 0.0001 and 6.05 for 65 yrs. Thus, 60 years was the most appropriate cut-off age in the present study.
Patients with negative Tg-DT values had an excellent prognosis [12] . The proportion of patients with negative Tg-DT values among the patients with BPD showed a significant decrease in the elderly patients: 50%, 69%, and 28% in the age groups, respectively, according to the age groups are shown in Fig. 1 . The proportion of patients with Tg-DT <2 years increased dramatically and significantly with age, being 6% in the young, 15% in the middle-aged, and 47% in the elderly patients, respectively (Table 4) .
In our univariate analyses of factors that may be related to Tg-DT <2 years, age ≥60 years was significant and Ex2 and T ≥4 cm were marginally significant, whereas male gender, cN1b and M1 were not associated with Tg-DT <2 years (Table 5 ). In the multivariate analysis, only age ≥60 years remained significant with a hazard ratio of 6.72 (Table 5 ). Regarding the (p = 0.0002) (data only shown in Fig. 1 ). The multivariate analysis of the negative Tg-DT values in the patients with BPD revealed that only age ≥60 years was the significant factor, which was inversely associated with negative Tg-DT values with a hazard ratio of 0.16 (p = 0.0001) (data not shown).
These results indicate that the tumor growth rate of hidden metastases, as indicated by Tg-DT, is strongly related to the patient age at surgery.
discussion
The TNM classification of malignant tumors of the UICC covers many malignant tumors of various organs [13] . The uniqueness of the TNM staging for thyroid carcinoma is that it involves age at diagnosis for staging [13] . This is due to the fact that elderly patients have had worse disease-specific survival than younger patients [4] [5] [6] [7] . Therefore, many other staging systems such as AMES, AGES, MACIS, and EORTC include age as one of the risk factors [14] [15] [16] [17] .
Interestingly, a high rate of recurrence with excellent survival was reported in young patients [8, 9] . Mazzaferri and Kloos wrote "Thyroid carcinoma is more lethal after age 40 years. The risk for cancer death increases with each subsequent decade of life, dramatically rising after age 60 years. However, there is a remarkably different pattern of tumor recurrence: rates are highest (40%) at the extremes of life, before age 20 years and after age 60 years" [18] . However, there are no clear explanations for these age-related phenomena.
We reported that Tg-DT was a potent prognostic indicator in patients with papillary carcinoma and undetectable TgAb who underwent total thyroidectomy, and that about one-third of the patients had biochemically persistent disease (BPD) postoperatively [12] . In the present new analyses of the data gathered for our previous report, we focused on factors that were related to BPD and Tg-DT. "BPD" indicates that patients with this status carry residual tumors or hidden metastases postoperatively [10, 11] , and a tumor marker's doubling time is thought to indicate the speed of the growth of residual tumors of individual patients with persistent disease [19] .
In the present study, the proportion of patients with BPD was significantly higher in the young patients and the elderly patients than in the middle-aged patients. This pattern was similar to the age-related incidence of recurrence reported by Mazzaferri and Kloos [18] . However, our present multivariate analysis of prognostic factors for BPD revealed that cN1b, T ≥4 cm, and Ex2 were significant factors, and that age ≥60 years was marginally insignificant, whereas age <40 years was not associated with BPD. These results indicate that the risk of carrying residual tumors or hidden metastases postoperatively correlates strongly with the extent of disease status.
The young patients in the present study had more advanced disease than the middle-aged patients, and this was the reason why a higher proportion of the young patients had BPD. Although the young patients often carried residual disease postoperatively, their prognosis was excellent. This was probably because most of their tumors were slow-growing or even possibly regressing, as indicated by the long or negative Tg-DT values in these patients.
In the present study cohort, all patients who died of the disease had Tg-DT <2 years, which indicated rapid tumor growth. The proportion of patients with Tg-DT <2 years among those with BPD increased with age, rising markedly after the age of 60. This phenomenon is in accordance with the description of dramatic increases in the risk of cancer death after the age of 60 by Mazzaferri and Kloos [18] . Our multivariate analysis of Tg-DT <2 years in the patients with BPD revealed that only age ≥60 years at surgery and none of the other classical prognostic factors remained significant.
In the present cohort, 17% of the study patients, or 51% of the patients with BPD, had negative Tg-DT values, since their Tg levels decreased over time. When we wrote our previous report, we could not tell whether the Tg in these patients came from residual normal thyroid tissue or hidden metastases, since most patients had not received thyroid ablation with 131 I [12] . To clarify this issue, we measured serum Tg in 22 consecutive patients with medullary thyroid carcinoma who underwent total thyroidectomy using similar surgical techniques for PTC [20] . All of them had undetectable serum Tg levels postoperatively, suggesting that the Tg in the patients with negative Tg-DT values came from hidden metastases and not from residual normal thyroid tissue [20] .
In patients with small changes in serum Tg values, variations in Tg assays results may give erroneous negative Tg-DT values by chance. If this was the case in the present study, the numbers of positive Tg-DT values and negative Tg-DT values should have been sim-of individual patients seems to be determined by the presence or absence of residual tumors, the volume of residual tumors, and the growth rate of tumors that is indicated by tumor marker-DT [21] . These findings may explain why tumor marker-DT had a very strong impact on prognosis in patients with medullary thyroid carcinoma [19, 22] and also in those with papillary carcinoma [12] . If a patient has a 1 mg residual tumor, after 10 doublings, the tumor will grow to about 1 g, which may become clinically detectable. If a patient has a 1 g residual tumor, after 10 doublings, the tumor will grow to about 1000 g, which almost kills the host [21, 23] . For tumors with DTs of 2 years, that will be 20 years after surgery. These simple calculations may help us understand that cancers with DTs >2 years are slow-growing and clinically less aggressive. The limitation is, however, that we can calculate tumor markerDTs only after a certain period of observation postoperatively.
In conclusion, the current analyses indicate that (1) BPD correlates strongly with the extent of disease status, and (2) the Tg-DT correlates with the patient's age at surgery. Although our results clearly indicate that the biological behavior of PTC is age-related, the exact reason for this remains to be established. acknowledgements Akira Miyauchi constructed the study design, Takumi Kudo analyzed the data, and the other coauthors contributed by performing surgery and caring for patients. We thank Miss Miwa Miyauchi for preparing the manuscript and Professor Samuel Refetoff for his critical review of the manuscript.
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The authors declare that there are no competing financial interests in relation to this article. ilar. However, this was not the case; the number of patients showing slow and mild increases in Tg values over time as indicated by Tg-DT ≥6 years (n = 17) was much smaller than the number of patients with negative Tg-DT values (n = 72). Therefore, most of the negative Tg-DT patients actually had decreases in serum Tg values during TSH suppressive therapy. Although this does not directly indicate shrinkage of hidden metastatic tumors, it does suggest that the tumors responded to TSH suppressive therapy-at least in the production of Tg.
In the present analyses, we also found that the percentage of patients with negative Tg-DT values among the elderly patients with BPD was significantly lower than the percentages in the young and middle-aged patients with BPD. The multivariate analysis revealed that only age ≥60 years was significantly and inversely associated with negative Tg-DT. This gives an additional explanation for the poor prognosis in elderly patients.
The length of Tg-DT in our individual patients with papillary carcinoma varied over a very wide range, as was the case for the length of calcitonin-DT in patients with medullary thyroid carcinoma [19] . The length of Tg-DT also varied greatly with age. In the young and middle-aged patients, the percentage of patients with short Tg-DT values was low, and the percentage with negative Tg-DT values was as high as 50% or more. In our elderly patients, the percentage of patients with short Tg-DT was increased and that with negative Tg-DT was decreased. These findings may explain why elderly patients had poorer survival than young or middle-aged patients. However, the reasons for these age-related changes in Tg-DT remain to be clarified.
Patients with advanced cancers are more likely to carry residual tumors postoperatively than patients with less advanced cancers. However, an advanced cancer per se does not indicate the presence or absence of residual tumors postoperatively. The prognosis references
